Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation.
Kueiyu Joshua LinDaniel E SingerJerry AvornEdwin Kevin HeistSushama Kattinakere SreedharaPriyanka AnandYichi ZhangTheodore N TsacogianisSebastian G SchneeweissPublished in: Circulation. Cardiovascular quality and outcomes (2024)
Among patients with atrial fibrillation receiving stroke-preventive therapy, LAAO use increased rapidly from 2015 to 2020 and was positively associated with the risk factors for OAC complications but negatively associated with old age, advanced frailty, and cancer. Black race and female sex were associated with a lower likelihood of receiving LAAO.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial appendage
- catheter ablation
- left atrial
- papillary thyroid
- direct oral anticoagulants
- heart failure
- case report
- percutaneous coronary intervention
- squamous cell
- risk factors
- community dwelling
- young adults
- mesenchymal stem cells
- squamous cell carcinoma
- stem cells
- coronary artery disease
- venous thromboembolism
- acute coronary syndrome
- mitral valve